Search research articles
Contact Us
Filters
Showing results (671-680 of 718) with videos related to
Page
of 72
Sort By:
Neuro-Oncology
|
February 28, 2026
DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma
Kristen L Drucker, Arijit Panda, Paul A Decker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 2024
Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models
Sonia Jain, Jessica I Griffith, Kendra A Porath, et al.
Neuro-Oncology Advances
|
July 25, 2025
Dissecting the biology of gliomagenesis: Evaluating the interaction between <i>IDH</i> tumor mutation and germline variants
Matthew L Kosel, Paul A Decker, Thomas M Kollmeyer, et al.
Molecular Cancer Research : MCR
|
February 22, 2022
Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition
Masum Rahman, Ian Olson, Moustafa Mansour, et al.
Neuro-Oncology Advances
|
March 30, 2026
Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, <i>IDH</i>-wildtype
Daniel H Lachance, Paul A Decker, Thomas M Kollmeyer, et al.
Molecular Cancer Therapeutics
|
January 15, 2024
Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts
Jianxiong Ji, Sonja Dragojevic, Cameron M Callaghan, et al.
Journal of the National Cancer Institute
|
November 29, 2015
Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma
Shiv K Gupta, Sani H Kizilbash, Brett L Carlson, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
December 13, 2016
Development and impact of arrhythmias after the Norwood procedure: A report from the Pediatric Heart Network
Matthew E Oster, Shan Chen, Nicholas Dagincourt, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 29, 2025
Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma: utility for detection versus monitoring
Cecile Riviere-Cazaux, Yuta Suzuki, Zain Kizilbash, et al.
Neuro-Oncology Advances
|
February 10, 2026
Pharmacokinetic-pharmacodynamic-efficacy modeling of the MDM2 inhibitor brigimadlin in glioblastoma patient-derived xenografts
Rachael A Vaubel, Wenjuan Zhang, Nishika Karbhari, et al.
Page
of 72
Search research articles
Search
Showing results (671-680 of 718) with videos related to
Sort By:
Page
of 72
Neuro-Oncology
|
February 28, 2026
DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma
Kristen L Drucker, Arijit Panda, Paul A Decker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 2024
Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models
Sonia Jain, Jessica I Griffith, Kendra A Porath, et al.
Neuro-Oncology Advances
|
July 25, 2025
Dissecting the biology of gliomagenesis: Evaluating the interaction between <i>IDH</i> tumor mutation and germline variants
Matthew L Kosel, Paul A Decker, Thomas M Kollmeyer, et al.
Molecular Cancer Research : MCR
|
February 22, 2022
Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition
Masum Rahman, Ian Olson, Moustafa Mansour, et al.
Neuro-Oncology Advances
|
March 30, 2026
Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, <i>IDH</i>-wildtype
Daniel H Lachance, Paul A Decker, Thomas M Kollmeyer, et al.
Molecular Cancer Therapeutics
|
January 15, 2024
Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts
Jianxiong Ji, Sonja Dragojevic, Cameron M Callaghan, et al.
Journal of the National Cancer Institute
|
November 29, 2015
Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma
Shiv K Gupta, Sani H Kizilbash, Brett L Carlson, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
December 13, 2016
Development and impact of arrhythmias after the Norwood procedure: A report from the Pediatric Heart Network
Matthew E Oster, Shan Chen, Nicholas Dagincourt, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 29, 2025
Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma: utility for detection versus monitoring
Cecile Riviere-Cazaux, Yuta Suzuki, Zain Kizilbash, et al.
Neuro-Oncology Advances
|
February 10, 2026
Pharmacokinetic-pharmacodynamic-efficacy modeling of the MDM2 inhibitor brigimadlin in glioblastoma patient-derived xenografts
Rachael A Vaubel, Wenjuan Zhang, Nishika Karbhari, et al.
Page
of 72